Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

被引：3

作者：

Khanna, Saira ^{[1
]}

Mackin, Anna G. ^{[1
]}

Dao, David T. ^{[1
]}

Komati, Rahul ^{[2
]}

Morocco, Perry C. ^{[3
]}

LaBelle, James L. ^{[4
]}

Shah, Hassan A. ^{[1
]}

Blair, Michael P. ^{[1
,5
]}

机构：

[1] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA

[2] Georgia Retina, Atlanta, GA USA

[3] Univ Chicago, Comer Childrens Hosp, Dept Pediat, Chicago, IL 60637 USA

[4] Univ Chicago, Dept Pediat, Corner Childrens Hosp, Sect Hematol Oncol Stem Cell Transplantat, Chicago, IL 60637 USA

[5] Retina Consultants Ltd, 2454 E Dempster St,Suite 400, Des Plaines, IL 60016 USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2022年 / 53卷 / 02期

关键词：

D O I：

10.3928/23258160-20220124-01

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Chimeric antigen receptor (CAR) T-cell therapy has become a novel approach in the treat-ment of many hematologic malignancies. However, ocular adverse effects have not been well described. This report presents a case of a pediatric patient with relapsed B-cell acute lymphoblastic leukemia with ocular involvement treated with CAR T-cell therapy who developed an exudative retinal de-tachment likely secondary to an inflammatory re-sponse to CAR T-cell therapy.

引用

页码：113 / 115

页数：3

共 50 条

[41] Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients
Arnold, Danielle E.
Maude, Shannon L.
Callahan, Colleen A.
DiNofia, Amanda M.
Grupp, Stephan A.
Heimall, Jennifer R.
PEDIATRIC BLOOD & CANCER, 2020, 67 (03)
[42] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
Li, Amanda M.
Hucks, George E.
Dinofia, Amanda M.
Seif, Alix E.
Teachey, David T.
Baniewicz, Diane
Callahan, Colleen
Fasano, Christina
McBride, Beth
Gonzalez, Vanessa
Nazimuddin, Farzana
Porter, David L.
Lacey, Simon F.
June, Carl H.
Grupp, Stephan A.
Maude, Shannon L.
BLOOD, 2018, 132
[43] Chimeric antigen receptor T-cell neuropsychiatric toxicity in acute lymphoblastic leukemia
Prudent, Vasthie
Breitbart, William S.
PALLIATIVE & SUPPORTIVE CARE, 2017, 15 (04) : 499 - 503
[44] ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Ruella, M.
Shestova, O.
Kenderian, S.
Barrett, D.
Grupp, S.
Scholler, J.
Lacey, S.
Kalos, M.
June, C. H.
Gill, S.
CYTOTHERAPY, 2014, 16 (04) : S8 - S8
[45] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
[46] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
[47] Cost-effectiveness of chimeric antigen receptor T-cell therapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
Sarkar, Reith
Gloude, Nicholas Joseph
Murphy, James Don
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[48] Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
卓亚琪
China Medical Abstracts(Internal Medicine), 2024, 41 (02) : 123
[49] Post-chimeric antigen receptor T-cell therapy haematopoietic stem cell transplantation for 52 cases with refractory/relapsed B-cell acute lymphoblastic leukaemia
Zhang, Yan
Chen, Huiren
Song, Yanzhi
Tan, Xiyou
Zhao, Yongqiang
Liu, Xiaodong
Li, Zhihui
Yang, Fan
Jiang, Min
Gao, Zhiyong
Wu, Tong
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : 146 - 152
[50] Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia
Myers, Regina M.
Dolan, Joseph
Teachey, David T.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (10) : 1029 - 1042

← 1 2 3 4 5 →